MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 16,030 shares, a decline of 75.0% from the May 31st total of 64,138 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 1,406,144 shares, the days-to-cover ratio is presently 0.0 days.
MariMed Stock Down 3.6%
MRMD stock traded down $0.00 during trading on Friday, hitting $0.07. 204,433 shares of the stock traded hands, compared to its average volume of 525,078. MariMed has a 1 year low of $0.06 and a 1 year high of $0.23. The firm’s 50 day moving average is $0.08 and its two-hundred day moving average is $0.08. The stock has a market cap of $28.02 million, a price-to-earnings ratio of -2.34 and a beta of 1.30. The company has a debt-to-equity ratio of 1.67, a current ratio of 0.95 and a quick ratio of 0.34.
MariMed (OTCMKTS:MRMD – Get Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01). The business had revenue of $39.48 million during the quarter, compared to analyst estimates of $38.75 million. MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. On average, sell-side analysts anticipate that MariMed will post -0.04 EPS for the current year.
MariMed Company Profile
MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.
The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.
Recommended Stories
- Five stocks we like better than MariMed
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
